US20010025118A1 - Process for preparing substituted benzoyl cyanide amidinohydrazones - Google Patents

Process for preparing substituted benzoyl cyanide amidinohydrazones Download PDF

Info

Publication number
US20010025118A1
US20010025118A1 US09/789,634 US78963401A US2001025118A1 US 20010025118 A1 US20010025118 A1 US 20010025118A1 US 78963401 A US78963401 A US 78963401A US 2001025118 A1 US2001025118 A1 US 2001025118A1
Authority
US
United States
Prior art keywords
compound
formula
mixture
cyanide
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/789,634
Other versions
US6329521B2 (en
Inventor
Vladimir Nadaka
Jael Lexmer
Joseph Kaspi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wavelength Pharmaceuticals Ltd
Original Assignee
Chemagis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemagis Ltd filed Critical Chemagis Ltd
Assigned to CHEMAGIS LTD. reassignment CHEMAGIS LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KASPI, JOSEPH, LEXNER, JAEL, NADAKA, VLADIMIR
Publication of US20010025118A1 publication Critical patent/US20010025118A1/en
Application granted granted Critical
Publication of US6329521B2 publication Critical patent/US6329521B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms

Definitions

  • the present invention relates to a method for preparing substituted benzoyl cyanide amidinohydrazones. More particularly, the present invention pertains to the preparation of these compounds by a reaction of substituted benzoyl cyanides with aminoguanidine in the presence of polyphosphoric acid.
  • a particularly preferred compound of this type is 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine (e.g. European Patent 21121).
  • a known process for preparing 3,5-diamino-6-(substituted phenyl)-1,2,4-triazines comprises reacting substituted benzoyl cyanides with aminoguanidine in aqueous solutions of strong acids such as nitric acid (J. A. Settepani and A. B. Borkovec, J. Heterocycl. Chem., 1966, 3, 188, U.S. Pat. Nos. 3,637,688; 4,486,354; 4,602,017; 4,649,139, R. W. A. Rees et al, J. Med. Chem., 1972, 15, 859; European Patent Nos.
  • R 1 is halogen, C 1-4 alkyl or trifluoromethyl
  • R 2 is hydrogen, halogen, C 1-4 alkyl or trifluoromethyl
  • R 1 and R 2 form a —CH ⁇ CH—CH ⁇ CH— group optionally substituted by a halogen atom or a C 1-4 alkyl or trifluoromethyl group
  • R 3 and R 4 are independently selected from hydrogen, halogen, C 1-4 alkyl or trifluoromethyl groups
  • R 5 is hydrogen, methyl or fluorine.
  • the ring closure is normally carried out by refluxing in an alcohol, such as methanol, ethanol, 1-propanol and the like, in the presence of a strong base, such as sodium hydroxide, potassium hydroxide and the like.
  • an alcohol such as methanol, ethanol, 1-propanol and the like
  • a strong base such as sodium hydroxide, potassium hydroxide and the like.
  • the present inventors have found the method for preparing the substituted benzoyl cyanide amidinohydrazones by a reaction of substituted benzoyl cyanides with aminoguanidine in a mixture of polyphosphoric acid and a solvent in the absence of water which minimizes the hydrolysis of the benzoyl cyanides.
  • substituted benzoyl cyanide amidinohydrazones can be prepared in higher yield after the reaction of substituted benzoyl cyanide with aminoguanidine in a mixture of polyphosphoric acid and acetonitrile for 24 hours.
  • the present invention provides a process for preparing a compound of the general formula (I):
  • R 1 to R 5 are independently selected from hydrogen, halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl or C 1-6 alkoxy, all optionally substituted by one or more of halogen, hydroxy and aryl groups, as well as being independently selected from amino, mono- or disubstituted amino, alkenyloxy, acyl, acyloxy, cyano, nitro, aryl and alkylthio groups, which process comprises reacting a compound of the general formula (II):
  • R 1 to R 5 are as defined in formula (I), with aminoguanidine bicarbonate in a mixture of a water-soluble solvent and polyphosphoric acid.
  • the total number of carbon atoms in R 1 to R 5 is less than eight.
  • the phenyl ring will suitably contain up to three substituents and preferably one or two substituents.
  • R 1 to R 5 are preferably independently selected from halogen and hydrogen. Particularly preferred substitutions are 4 or 2,3 or 2,4 or 3,4 mono- or di- halo (especially chloro).
  • Preferred compounds are:
  • the amount of aminoguanidine bicarbonate is preferable more than one equivalent and more preferable 1.5 molar equivalents relative to compound of the formula (II).
  • the amount of polyphosphoric acid is preferably from 4 to 8 g, and more preferably 5.5 g to one gram of the compound of formula (II).
  • the reaction solvents are preferably water-soluble solvents such as acetonitrile, tetrahydrofuran, 1,2-dimethoxyethane (monoglyme), 2-methoxyethyl ether (diglyme) and the like and more preferably acetonitrile.
  • the amount of the reaction solvent is preferably from 2 to 8 ml, and more preferably 5 ml to one gram of the compound of the formula (II).
  • the reaction temperature may be chosen from ambient temperature to the reflux temperature of the solvent, and more preferably the temperature is between 50-70° C.
  • the reaction may be stopped after the disappearance of the starting material.
  • amidinohydrazones of the formula (I) exist as two isomers (E- and Z-forms), for the purpose of the present invention, these compounds may exist as either of the isomers or as a mixture thereof.
  • the wet phosphate of the compound of the formula (I) is added to an aqueous alkali solution, e.g., sodium hydroxide and the like, and the mixture is stirred at ambient temperature for one hour. A precipitate is then collected by filtration, washed with water and dried at 80° C. to give a free base of the compound of the formula (I).
  • an aqueous alkali solution e.g., sodium hydroxide and the like
  • R 1 to R 5 are as defined in the formula (I)
  • R 1 to R 5 can be obtained from the compound of the formula (I) by a procedure similar to that described in the literature, i.e. Beyer et al, Chem. Ber. 1960, 93, 2209; J. A. Settepani and A. B. Borkovec, J. Heterocycl. Chem., 1966, 3, 188, U.S. Pat. No. 3,637,688; R. W. A. Rees et al, J. Med. Chem., 1972, 15, 859; European Patent Nos. 21,121; 247,892.
  • the compounds of the formula (I) can be obtained in high yield from the compound of the formula (II) by using polyphosphoric acid and simple procedures.
  • Example 2(a) The title compound was prepared as in Example 2(a) from 2,4-dichlorobenzoyl cyanide amidinohydrazone obtained in Example 3.
  • the solvent for ring closure was a mixture of 1-propanol and dimethylsulfoxide (5:1). Total yield (from 2,4-dichlorobenzoyl cyanide): 55%; m.p. 220-222° C. (uncorrected).
  • Example 2(a) The title compound was prepared as in Example 2(a) from 3,4-dichlorobenzoyl cyanide amidinohydrazone obtained in Example 5.
  • the solvent for the ring closure was a mixture of 1-propanol and dimethyl sulfoxide (1:1). Total yield (from 3,4-dichlorobenzoyl cyanide): 76%; m.p. 222-224° C. (uncorrected).
  • Example 2(a) The title compound was prepared as in Example 2(a) from 4-chlorobenzoyl cyanide amidinohydrazone obtained in Example 7.
  • the solvent for the ring closure was a mixture of 1-propanol and dimethyl sulfoxide (4:1). Total yield (from 4-chlorobenzoyl cyanide): 72%; m.p. 219-221° C. (uncorrected).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a process for preparing a compound of the general formula (I):
Figure US20010025118A1-20010927-C00001
wherein R1 to R5 are independently selected from hydrogen, halogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl or C1-6 alkoxy, all optionally substituted by one or more of halogen, hydroxy and aryl groups, as well as being independently selected from amino, mono- or disubstituted amino, alkenyloxy, acyl, acyloxy, cyano, nitro, aryl and alkylthio groups, which process comprises reacting a compound of the general formula (II):
Figure US20010025118A1-20010927-C00002
wherein R1 to R5 are as defined in formula (I), with aminoguanidine bicarbonate in a mixture of a water-soluble solvent and polyphosphoric acid.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a method for preparing substituted benzoyl cyanide amidinohydrazones. More particularly, the present invention pertains to the preparation of these compounds by a reaction of substituted benzoyl cyanides with aminoguanidine in the presence of polyphosphoric acid. [0001]
  • BACKGROUND OF THE INVENTION
  • It is known that certain 3,5-diamino-6-(substituted phenyl)-1,2,4-triazines are active in the treatment of CNS disorders, such as psychiatric and neurological disorders, and are also useful as anticonvulsants, for example in the treatment of epilepsy. These triazines are also non-depressant at therapeutic dose levels and are therefore advantageous as compared with depressant anti-epileptics such as phenobarbitone. [0002]
  • A particularly preferred compound of this type is 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine (e.g. European Patent 21121). [0003]
  • A known process for preparing 3,5-diamino-6-(substituted phenyl)-1,2,4-triazines, comprises reacting substituted benzoyl cyanides with aminoguanidine in aqueous solutions of strong acids such as nitric acid (J. A. Settepani and A. B. Borkovec, J. Heterocycl. Chem., 1966, 3, 188, U.S. Pat. Nos. 3,637,688; 4,486,354; 4,602,017; 4,649,139, R. W. A. Rees et al, J. Med. Chem., 1972, 15, 859; European Patent Nos. 21,121; 142,306; 247,892, Israeli Patent Nos. 60,201; 73,332; 82,710) and sulfuric acid (European Patent No. 247,892, Israeli Patent No. 82,710) to produce amidinohydrazone of the general formula (A): [0004]
    Figure US20010025118A1-20010927-C00003
  • wherein R[0005] 1 is halogen, C1-4 alkyl or trifluoromethyl, R2 is hydrogen, halogen, C1-4 alkyl or trifluoromethyl, or R1 and R2 form a —CH═CH—CH═CH— group optionally substituted by a halogen atom or a C1-4 alkyl or trifluoromethyl group, R3 and R4 are independently selected from hydrogen, halogen, C1-4 alkyl or trifluoromethyl groups and R5 is hydrogen, methyl or fluorine.
  • 3,5-Diamino-6-(substituted phenyl)-1,2,4-triazines (compounds of the general formula (B): [0006]
    Figure US20010025118A1-20010927-C00004
  • wherein R[0007] 1-R5 are as hereinbefore defined) are obtained by ring closure of a compound of the formula A.
  • The ring closure is normally carried out by refluxing in an alcohol, such as methanol, ethanol, 1-propanol and the like, in the presence of a strong base, such as sodium hydroxide, potassium hydroxide and the like. [0008]
  • However, the reaction of substituted benzoyl cyanides with aminoguanidine in the aqueous solutions of strong acids is very slow and usually from 2 to 21 days are required to complete this reaction. On the other hand, substituted benzoyl cyanides are hydrolyzed at the reaction conditions, and overall yield of the triazines is low (from 2 to 41%) (Table). [0009]
    TABLE
    Yield
    of the
    Tem- compound
    Compounds perature Time of of the
    of the Solvent of the of the the formula
    formula (A) reaction reaction reaction (B)
    R6═R7═Cl a) DMSO and 8N 25° C.  7 days 15.6%*
    R8═R9═R10═H aqueous nitric
    acid
    b) Acetonitrile 20-30° C. 48 hours 41%** 
    and 63%
    aqueous sulfuric
    acid
    R6═R7═R9═Cl DMSO and 8N 20-30° C. 21 days  1.6%*
    R8═R10═H aqueous nitric
    acid
    R6═R8═Cl DMSO and 8N 25° C. 24 hours  8%***
    R7═R9═R10═H aqueous nitric
    acid
    R7═R8═Cl DMSO and 8N 25° C. 24 hours 23%***
    R6═R9═R10═H aqueous nitric
    acid
    R8═Cl DMSO and 8N 25° C. 24 hours 37%***
    R6═R7═R9 aqueous nitric
    R10═H acid
  • SUMMARY OF THE INVENTION
  • As a result of research to solve the drawbacks of the prior art methods, the present inventors have found the method for preparing the substituted benzoyl cyanide amidinohydrazones by a reaction of substituted benzoyl cyanides with aminoguanidine in a mixture of polyphosphoric acid and a solvent in the absence of water which minimizes the hydrolysis of the benzoyl cyanides. [0010]
  • According to the present invention substituted benzoyl cyanide amidinohydrazones can be prepared in higher yield after the reaction of substituted benzoyl cyanide with aminoguanidine in a mixture of polyphosphoric acid and acetonitrile for 24 hours. [0011]
  • Other objects and advantages of the present invention will be apparent from the following description. [0012]
  • DETAILED DESCRIPTION OF THE INVENTION
  • More specifically, the present invention provides a process for preparing a compound of the general formula (I): [0013]
    Figure US20010025118A1-20010927-C00005
  • wherein R[0014] 1 to R5 are independently selected from hydrogen, halogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl or C1-6 alkoxy, all optionally substituted by one or more of halogen, hydroxy and aryl groups, as well as being independently selected from amino, mono- or disubstituted amino, alkenyloxy, acyl, acyloxy, cyano, nitro, aryl and alkylthio groups, which process comprises reacting a compound of the general formula (II):
    Figure US20010025118A1-20010927-C00006
  • wherein R[0015] 1 to R5 are as defined in formula (I), with aminoguanidine bicarbonate in a mixture of a water-soluble solvent and polyphosphoric acid.
  • Suitably the total number of carbon atoms in R[0016] 1 to R5 is less than eight.
  • The phenyl ring will suitably contain up to three substituents and preferably one or two substituents. [0017]
  • R[0018] 1 to R5 are preferably independently selected from halogen and hydrogen. Particularly preferred substitutions are 4 or 2,3 or 2,4 or 3,4 mono- or di- halo (especially chloro).
  • Preferred compounds are: [0019]
  • 4-Chlorobenzoyl cyanide amidinohydrazone, [0020]
  • 2,3-Dichlorobenzoyl cyanide amidinohydrazone, [0021]
  • 2,4-Dichlorobenzoyl cyanide amidinohydrazone, [0022]
  • 3,4-Dichlorobenzoyl cyanide amidinohydrazone. [0023]
  • The preparation of the compounds of the formula (II) is analogous to that described in the literature, i.e. U.S. Pat. No. 3,637,688; R. W. A. Rees et al, J. Med. Chem., 1972, 15, 859. [0024]
  • The amount of aminoguanidine bicarbonate is preferable more than one equivalent and more preferable 1.5 molar equivalents relative to compound of the formula (II). [0025]
  • The amount of polyphosphoric acid is preferably from 4 to 8 g, and more preferably 5.5 g to one gram of the compound of formula (II). [0026]
  • The reaction solvents are preferably water-soluble solvents such as acetonitrile, tetrahydrofuran, 1,2-dimethoxyethane (monoglyme), 2-methoxyethyl ether (diglyme) and the like and more preferably acetonitrile. [0027]
  • The amount of the reaction solvent is preferably from 2 to 8 ml, and more preferably 5 ml to one gram of the compound of the formula (II). [0028]
  • The reaction temperature may be chosen from ambient temperature to the reflux temperature of the solvent, and more preferably the temperature is between 50-70° C. [0029]
  • Since the progress of the reaction can be monitored by using high performance liquid chromatography, the reaction may be stopped after the disappearance of the starting material. [0030]
  • Although amidinohydrazones of the formula (I) exist as two isomers (E- and Z-forms), for the purpose of the present invention, these compounds may exist as either of the isomers or as a mixture thereof. [0031]
  • After completion of the reaction, water is added to the reaction mixture to obtain a clear homogeneous mixture. The mixture is dropped to water, and a colourless precipitate is collected by filtration to obtain a wet phosphate of the compound of the formula (I). [0032]
  • The wet phosphate of the compound of the formula (I) is added to an aqueous alkali solution, e.g., sodium hydroxide and the like, and the mixture is stirred at ambient temperature for one hour. A precipitate is then collected by filtration, washed with water and dried at 80° C. to give a free base of the compound of the formula (I). [0033]
  • Triazines of the general formula (III): [0034]
    Figure US20010025118A1-20010927-C00007
  • wherein R[0035] 1 to R5 are as defined in the formula (I), can be obtained from the compound of the formula (I) by a procedure similar to that described in the literature, i.e. Beyer et al, Chem. Ber. 1960, 93, 2209; J. A. Settepani and A. B. Borkovec, J. Heterocycl. Chem., 1966, 3, 188, U.S. Pat. No. 3,637,688; R. W. A. Rees et al, J. Med. Chem., 1972, 15, 859; European Patent Nos. 21,121; 247,892.
  • According to the present invention, the compounds of the formula (I) can be obtained in high yield from the compound of the formula (II) by using polyphosphoric acid and simple procedures. [0036]
  • The present invention will be concretely illustrated by Exam, which show the method for preparation of the compound of formula (I). [0037]
  • While the invention will now be described in connection with certain preferred embodiments in the following examples so that aspects thereof may be more fully understood and appreciated, it is not intended to limit the invention to these particular embodiments. On the contrary, it is intended to cover all alternatives, modifications and equivalents as may be included within the scope of the invention as defined by the appended claims. Thus, the following examples which include preferred embodiments will serve to illustrate the practice of this invention, it being understood that the particulars shown are by way of example and for purposes of illustrative discussion of preferred embodiments of the present invention only and are presented in the cause of providing what is believed to be the most useful and readily understood description of formulation procedures as well as of the principles and conceptual aspects of the invention.[0038]
  • EXAMPLE 1 Preparation of 2,3-Dichlorobenzoyl cyanide amidinohydrazone
  • a) Reactor (0.5 L) was charged under nitrogen with acetonitrile (200 ml) and polyphosphoric acid (220 g), and the mixture was stirred for 0.5 hour to obtain an emulsion. Solid 2,3-dichlorobenzoyl cyanide (41 g, 0.2 mole; assay 97.5%) was added to the emulsion. Aminoguanidine bicarbonate (41 g, 0.3 mole; assay 99.0%) was added to the mixture in 5 equal portions during 2 hours at 30-40° C. The reaction mixture was stirred at 50° C. during 22 hours. Water (40 ml) was then added to the reaction mixture to obtain a clear homogeneous mixture. The mixture was dropped to water at slow stirring for 0.5 hour, and the precipitate was collected by filtration to give wet phosphate salt of 2,3-dichlorobenzoyl cyanide amidinohydrazone. [0039]
  • The wet phosphate salt was added at ambient temperature to 2.5% aqueous sodium hydroxide solution (500 ml), and the mixture was stirred for 0.5 hour. The precipitate was collected by filtration, washed thoroughly with water and dried at 80° C. overnight to give 43.0 g (84% yield) of 2,3-dichlorobenzoyl cyanide amidinohydrazone base. [0040]
  • m.p. 221-222° C. (uncorrected) (after dissolution in tetrahydrofuran, filtration of the solution and removal of the solvent to dryness in vacuo). [0041]
  • [0042] 1H NMR (DMSO-d6): δ (ppm)=6.7 (4H, s, NH), 7.3-7.7 (3H, m, ArH). 13C NMR (DMSO-d6): δ (ppm)=113.88 and 114.53 (C≡N, d, E- and Z-forms of the hydrazone), 128.24, 129.53 and 130.10 (3C—H from Ar), 163.64 [—NH—C(NH2)═NH]. MS (FAB): m/z 256 (MH+). Analysis: Calcd. for C9H7Cl2N5: C, 42.21; H, 2.75; N, 27.35, found: C, 42.12; H, 2.77; N, 27.80.
  • b) The title compound was obtained in 67% yield after carrying out the reaction of 2,3-dichlorobenzoyl cyanide with aminoguanidine in a mixture of monoglyme and polyphosphoric acid. [0043]
  • EXAMPLE 2 Preparation of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
  • a) The 2,3-dichlorobenzoyl cyanide amidinohydrazone base (43.0 g) obtained in Example 1(a) was heated under reflux in 1-propanol (560 ml) for two hours. The hot solution was filtered off, and the filtrate was cooled to 10° C. The crystals were collected by filtration, recrystallized from 1-propanol (490 ml) and dried at 100° C. to give 3,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazine (34.5 g). [0044]
  • The 1-propanol was evaporated to dryness in vacuo from the two filtrates, and the residue was recrystallized from 1-propanol to give 4.0 g of the title compound. [0045]
  • Total yield (from 2,3-dichlorobenzoyl cyanide): 38.5 g (75.2%), m.p. 216-218° C. (uncorrected). [0046]
  • [0047] 1H NMR (DMSO-d6): δ (ppm)=6.16 (2H, s, NH), 6.45 (2H, br s, NH), 7.2-7.7 (3H, m, ArH). 13C NMR (DMSO-d6): δ (ppm)=129.26, 131.35 and 131.51 (3 C—H from Ar), 155.114 [C—C(NH2)═N—], 162.95 [═N—C(NH2)═N—]. MS (FAB): m/z 256 (MH+).
  • b) Wet phosphate obtained by the procedure similar to that of Example 1(a) from 200 g (0.959 mole; assay: 95.91%) of 2,3-dichlorobenzoyl cyanide was added to 1-propanol (2.0 L), and the mixture was heated to 65° C. at stirring. 45% Aqueous sodium hydroxide solution (185 ml) was then added to this mixture to produce pH 10, and the mixture was heated under reflux for two hours. The water phase was collected, and the organic phase was cooled to 10° C. The colourless crystals were collected by filtration, recrystallized from 1-propanol (2.0 L) (the hot solution was filtered) and dried at 100° C. to give 160 g of the title compound. [0048]
  • An additional 20.0 g of the title compound was obtained from the filtrates. Total yield (from 2,3-dichlorobenzoyl cyanide): 180 g (73.3%). [0049]
  • c) The title compound was obtained in 60% total yield (from 2,3-dichiorobenzoyl cyanide) from 2,3-dichlorobenzoyl cyanide amidinohydrazone obtained in Example 1(b). [0050]
  • EXAMPLE 3 Preparation of 2,4-dichlorobenzoyl cyanide amidinohydrazone
  • The title compound was prepared as in Example 1(a). Yield: 65%. [0051] 1H NMR (DMSO-d6): δ (ppm)=6.70 (4H, s, NH), 7.4-7.8 (3H, m, ArH). 13C NMR (DMSO-d6): δ (ppm)=114.16 and 114.65 (C═N, d, E- and Z-forms of the hydrazone), 128.06, 130.05 and 132.22 (3 C—H from Ar), 163.87 [—NH—C(NH2)═NH]. MS (FAB): m/z 256 (MH+).
  • EXAMPLE 4 Preparation of 3,5-Diamino-6-(2,4-dichlorophenyl)-1,2,4-triazine
  • The title compound was prepared as in Example 2(a) from 2,4-dichlorobenzoyl cyanide amidinohydrazone obtained in Example 3. The solvent for ring closure was a mixture of 1-propanol and dimethylsulfoxide (5:1). Total yield (from 2,4-dichlorobenzoyl cyanide): 55%; m.p. 220-222° C. (uncorrected). [0052]
  • [0053] 1H NMR (DMSO-d6): δ (ppm)=6.40 (2H, s, NH), 6.66 (2H, br s, NH), 7.1-7.8 (3H, m, ArH). 13C NMR (DMSO-d6): δ (ppm)=127.60, 129.04 and 133.19 (3 C—H from Ar), 154.21 [C—C(NH2)═N—], 161.98 [═N—C(NH2)═N—]. MS (FAB): m/z 256 (MH+).
  • EXAMPLE 5 Preparation of 3,4-Dichlorobenzoyl cyanide amidinohydrazone
  • The title compound was prepared as in Example 1(a). Yield: 86%. [0054]
  • [0055] 1H NMR (DMSO-d6): δ (ppm)=7.28 (4H, s, NH), 7.5-8.3 (3H, m, ArH). 13C NMR (DMSO-d6): δ (ppm)=112.44 and 117.20 (C≡N, d, E- and Z-forms of the hydrazone), 125.20, 126.06 and 131.95 (3 C—H from Ar), 160.99 [—NH—C(NH2)═NH]. MS (FAB): m/z 256 (MH+).
  • EXAMPLE 6 Preparation of 3,5-Diamino-6-(3,4-dichlorophenyl)-1,2,4-triazine
  • The title compound was prepared as in Example 2(a) from 3,4-dichlorobenzoyl cyanide amidinohydrazone obtained in Example 5. The solvent for the ring closure was a mixture of 1-propanol and dimethyl sulfoxide (1:1). Total yield (from 3,4-dichlorobenzoyl cyanide): 76%; m.p. 222-224° C. (uncorrected). [0056]
  • [0057] 13C NMR (DMSO-d6): δ (ppm)=128.6, 130.24 and 130.83 (3 C—H from Ar), 155.02 [C—C(NH2)═N—], 158.99 [═N—C(NH2)═N—]. MS (FAB): m/z 256 (MH+).
  • EXAMPLE 7 Preparation of 4-Chlorobenzoyl cyanide amidinohydrazone
  • The title compound was prepared as in Example 1(a). Yield: 80%. [0058]
  • [0059] 1H NMR (DMSO-d6): δ (ppm)=6.70 (4H, s, NH), 7.2-8.0 (4H, m, ArH). 13C NMR (DMSO-d6): δ (ppm)=113.49 and 116.79 (C≡N, d, E- and Z-forms of the hydrazone), 125.95 and 128.44 (4 C—H from Ar), 163.90 [—NH—C(NH2)═NH]. MS (FAB): m/z 222 (MH+).
  • EXAMPLE 8 Preparation of 3,5-Diamino-6-(4-chlorophenyl)-1,2,4-triazine
  • The title compound was prepared as in Example 2(a) from 4-chlorobenzoyl cyanide amidinohydrazone obtained in Example 7. The solvent for the ring closure was a mixture of 1-propanol and dimethyl sulfoxide (4:1). Total yield (from 4-chlorobenzoyl cyanide): 72%; m.p. 219-221° C. (uncorrected). [0060]
  • [0061] 1H NMR (DMSO-d6): δ (p)=6.43 (2H, s, NH), 6.73 (2H, br s, NH), 7.3-7.7 (4H, m, ArH). 13C NMR (DMSO-d6): δ (ppm)=128.69 and 129.87 (4 C—H from Ar), 154.32 [C—C(NH2)═N—], 161.55 [═N—C(NH2)═N—]. MS (FAB): m/z 222 (MH+).
  • It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative examples and that the present invention may be embodied in other specific forms without departing from the essential attributes thereof, and it is therefore desired that the present embodiments and examples be considered in all respects as illustrative and not restrictive, reference being made to the appended claims, rather than to the foregoing description, and all changes which come within the meaning and range of equivalency of the claims aretherintended to be embraced ther. [0062]

Claims (6)

What is claimed is:
1. A process for preparing a compound of the general formula (I):
Figure US20010025118A1-20010927-C00008
wherein R1 to R5 are independently selected from hydrogen, halogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl or C1-6 alkoxy, all optionally substituted by one or more of halogen, hydroxy and aryl groups, as well as being independently selected from amino, mono- or disubstituted amino, alkenyloxy, acyl, acyloxy, cyano, nitro, aryl and alkylthio groups, which process comprises reacting a compound of the general formula (II):
Figure US20010025118A1-20010927-C00009
wherein R1 to R5 are as defined in formula (I), with aminoguanidine bicarbonate in a mixture of a water-soluble solvent and polyphosphoric acid.
2. A process according to
claim 1
wherein the amount of aminoguanidine bicarbonate is more than 1 equivalent per 1 equivalent of the compound of formula (II).
3. A process according to
claim 1
wherein the amount of polyphosphoric acid is from 4 to 8 g per one gram of the compound of formula (II).
4. A process according to
claim 1
wherein said water-soluble solvent is acetonitrile.
5. A process according to
claim 1
wherein the reaction of the compound of formula (II) with aminoguanidine bicarbonate is carried out at a temperature of about 25-150° C.
6. A process according to
claim 1
wherein the compound of formula (I) is 2,3-Dichlorobenzoyl cyanide amidinohydrazone.
US09/789,634 2000-02-25 2001-02-22 Process for preparing substituted benzoyl cyanide amidinohydrazones Expired - Fee Related US6329521B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL134730 2000-02-25
IL134,730 2000-02-25
IL13473000A IL134730A (en) 2000-02-25 2000-02-25 Process for preparing substituted benzoyl cyanide amidinohydrazones

Publications (2)

Publication Number Publication Date
US20010025118A1 true US20010025118A1 (en) 2001-09-27
US6329521B2 US6329521B2 (en) 2001-12-11

Family

ID=11073869

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/789,634 Expired - Fee Related US6329521B2 (en) 2000-02-25 2001-02-22 Process for preparing substituted benzoyl cyanide amidinohydrazones

Country Status (6)

Country Link
US (1) US6329521B2 (en)
EP (1) EP1127873A3 (en)
CA (1) CA2337280C (en)
HU (1) HUP0100740A3 (en)
IL (1) IL134730A (en)
PL (1) PL200223B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6535793B2 (en) * 2000-05-01 2003-03-18 Irobot Corporation Method and system for remote control of mobile robot
US20090065271A1 (en) * 1998-03-27 2009-03-12 Irobot Corporation Robotic Platform

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2366521C (en) * 2001-12-24 2007-03-06 Brantford Chemicals Inc. A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines
ES2209639B1 (en) 2002-10-31 2005-08-01 Vita Cientifica, S.L. PROCEDURE FOR OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND AND OBTAINING YOUR INTERMEDIATE.
GB2395483A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Crystalline lamotrigine and its monohydrate
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
EP2054396A1 (en) * 2006-08-14 2009-05-06 Lonza Ag A process for the preparation of lamotrigine
CN102766104A (en) * 2012-08-20 2012-11-07 三金集团湖南三金制药有限责任公司 Synthetic method of drug lamotrigine for curing bipolar disorder and epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
FI67844C (en) * 1979-06-01 1985-06-10 Wellcome Found PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC ANALYTICAL BAR 3,5-DIAMINO-6- (SUBSTITUTE PHENYL) -1,2,4-TRIAZINDERIVAT
GB8328757D0 (en) * 1983-10-27 1983-11-30 Wellcome Found Chemical compounds
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090065271A1 (en) * 1998-03-27 2009-03-12 Irobot Corporation Robotic Platform
US8365848B2 (en) 1998-03-27 2013-02-05 Irobot Corporation Robotic platform
US9248874B2 (en) 1998-03-27 2016-02-02 Irobot Corporation Robotic platform
US9573638B2 (en) 1998-03-27 2017-02-21 Irobot Defense Holdings, Inc. Robotic platform
US6535793B2 (en) * 2000-05-01 2003-03-18 Irobot Corporation Method and system for remote control of mobile robot

Also Published As

Publication number Publication date
EP1127873A2 (en) 2001-08-29
US6329521B2 (en) 2001-12-11
IL134730A0 (en) 2001-04-30
HU0100740D0 (en) 2001-04-28
HUP0100740A2 (en) 2001-11-28
HUP0100740A3 (en) 2003-05-28
IL134730A (en) 2003-10-31
PL346034A1 (en) 2001-08-27
EP1127873A3 (en) 2003-05-07
CA2337280C (en) 2008-03-18
PL200223B1 (en) 2008-12-31
CA2337280A1 (en) 2001-08-25

Similar Documents

Publication Publication Date Title
EP1007503B1 (en) New chemical compound suitable for use as an explosive, intermediate and method for preparing the compound
SU1055331A3 (en) Process for preparing derivatives of 3,5-diamino-1,2,4-triazine or their acid addition salts
RU2017736C1 (en) 5,6-dihydro-2-(substituted phenyl)-1,2,4-triazine-3,5-(2h,4h)-diones showing anticoxidial and coxidiostatic activity
US6329521B2 (en) Process for preparing substituted benzoyl cyanide amidinohydrazones
SU791236A3 (en) Method of preparing 1,2,4-triazin-5-one derivatives
EP0537611B1 (en) Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides
EP0730616B1 (en) Process for preparing polyazamacrocycles
US4677219A (en) Substituted benzonitriles
EP0708095B1 (en) Process for the preparation of alkoxytriazoles
US7390899B2 (en) Process for the synthesis of high purity 3,5-diamino-6-(2,3-dichlorophenyl) (1,2,4-triazine)
US7368464B2 (en) Preparation for the production of 1,2,4-triazolylmethyl-oxiranes
CA2155152A1 (en) Process for the preparation of 1,2,4-triazine-3,5-diones
US6680409B2 (en) Process for the preparation of robenidine and salts thereof
US6683182B2 (en) Method for producing lamotrigine from α-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction
KR100753354B1 (en) Process for preparing a pharmaceutically active compound and for preparing its intermediate
JPH07196630A (en) Production of triazolinone, and new intermediate
WO1999044996A1 (en) Process for preparing 3- hydroxy- 5-[(1, 4,5,6- tetrahydro-5-hydroxy- 2- pyrimidinyl)amino]benzoic acid
JPH0141617B2 (en)
JPH05255281A (en) Preparation of 2-hydroxy-4,6-diaryl-1,3,5-triazine
IE73669B1 (en) Process for the preparation of aminotriazine derivatives
RU2185382C2 (en) Method of synthesis of 2,3-pyridine dicarboximide and intermediate compound for its synthesis
JPH01186874A (en) Production of 3-mercapto-5-amino-(1h)-1, 2, 4-triazole
Shukurov et al. The reaction of 2-amino-7-methyl-5-oxo-5 H-1, 3, 4-thiadiazolo [3, 2-a]-pyrimidine with carbon disulfide and alkylation of its products
JPH0684340B2 (en) Formamidine formate
US20020120143A1 (en) Process for the preparation of 2,3-pyridinedicarboximides

Legal Events

Date Code Title Description
AS Assignment

Owner name: CHEMAGIS LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NADAKA, VLADIMIR;LEXNER, JAEL;KASPI, JOSEPH;REEL/FRAME:011629/0565

Effective date: 20010207

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20131211